Media/Press
Dr. Decotiis on Pix 11 News – Explaining Hormones & Weight Gain: Why Ozempic and Mounjaro Work
Dr. Decotiis on Fox & Friends: Discussing Weight Loss Pills
Dr. Decotiis on NY1 – Are Popular Weight Loss Drugs Safe: Ozempic, Liraglutide, Saxenda, Mounjaro
Dr. Decotiis on Fox News – PFAs & Obesity. Forever Chemicals Causing Obesity
Dr. Decotiis on Fox News – Discussion on Mounjaro, Ozempic, Semaglutide, & Tirzepatide
Dr. Decotiis on Fox News – Mounjaro Benefits
Dr. Decotiis Contributes to TheMessenger – Zepbound vs. Wegovy: How the Weight Loss Drugs Differ
Zepbound — Eli Lilly’s latest weight management medication — received approval from the Food and Drug Administration this week for use in adults who are obese or are overweight with at least one weight-related condition. If Zepbound sounds familiar, that’s because it is: The base drug is tirzepatide, which is the same as Eli Lilly’s Mounjaro. The […]
Dr. Decotiis Contributes to CBS News – Are morning workouts better for weight loss?
A new study suggests that what time of day a person chooses to work out might have an impact on their weight loss. There have been years of discussion about what time of day works best. Research and other studies have had conflicting answers, and medical weight loss physician Dr. Sue Decotiis told CBS News that really, the best exercise is […]
Dr. Decotiis Contributes to Fox News – Weight loss surgeries on the rise among kids and teens, study finds: ‘Altering the anatomy’
A growing number of kids and teens are turning to weight loss surgery amid rising rates of pediatric obesity, according to a new study published in JAMA Pediatrics. Between 2020 and 2021, there was a nearly 19% increase in weight loss surgeries among U.S. youths aged 10 to 19 years, as discovered by researchers from the University […]
